Vaccine | WHO EUL Holder | NRA of record | Recommendation issued |
---|---|---|---|
COMIRNATY® COVD-19 mRNA Vaccine (nucleoside modified) | BioNTech Manufacturing GmbH | 31 December 2020
16 July 2021 | |
Vaxzevria
| AstraZeneca AB / SK Bioscience Co. Ltd
| Ministry of Health, Labour and Welfare Therapeutic Goods Administration
| 15 February 2021
15 April 2021
21 August 2021
|
COVISHIELD™
| Serum Institute of India Pvt. Ltd | Central Drugs Standard Control Organization | 15 February 2021 |
COVID-19 Vaccine (Ad26.COV2-S [recombinant]) | Janssen–Cilag International NV | European Medicines Agency | 12 March 2021 |
Spikevax COVID-19 mRNA Vaccine (nucleoside modified) | Moderna Biotech
| 30 April 2021
| |
Inactivated COVID-19 Vaccine (Vero Cell) | Beijing Institute of Biological Products Co., Ltd. (BIBP) | National Medicinal Products Association | 07 May 2021 |
CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated | Sinovac Life Sciences Co., Ltd | National Medical Products Administration | 01 June 2021 |
COVAXIN® Covid-19 vaccine (Whole Virion Inactivated Corona Virus vaccine) | Bharat Biotech International Ltd | Central Drugs Standard Control Organization | 03 November 2021 |
COVOVAX™ COVID-19 vaccine (SARS-CoV-2 rS Protein Nanoparticle [Recombinant]) | Serum Institute of India Pvt. Ltd | 17 December 2021 | |
NUVAXOVID™ | Novavax CZ a.s. | European Medicines Agency | 20 December 2021 |